FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Amneal Pharmaceuticals of New York Oseltamivir Phosphate for Oral Suspension Recall

Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only…

Amneal Pharmaceuticals of New York, LLC · Brookhaven, NY

Risk level
Class II
Reported by FDA
Feb 28, 2024
Recall ID
D-0327-2024
Check your lot numberHow we source this data

Summary

Amneal Pharmaceuticals of New York recalled Oseltamivir Phosphate for Oral Suspension starting Feb 13, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0327-2024 on Feb 28, 2024. Reason: Failed Impurities/Degradation Specifications: Out-of-specification test results. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Out-of-specification test results.

Product description

Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC# 69238-1273-6

Lot numbers, UPCs & expiration codes

Lot # BF22722A, Exp. 08/31/2024; BJ15122A, Exp. 09/30/2024

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0327-2024
Classification
Class II
Status
Terminated
Recall initiated
Feb 13, 2024
FDA report date
Feb 28, 2024
Quantity
46,037 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Amneal Pharmaceuticals of New York, LLC

Original FDA data

Every field from FDA enforcement report D-0327-2024, exactly as published.

Show all FDA fields
City
Brookhaven
State
NY
Status
Terminated
Country
United States
Event ID
93959
Address
50 Horseblock Rd
Code information
Lot # BF22722A, Exp. 08/31/2024; BJ15122A, Exp. 09/30/2024
Postal code
11719-9509
Report date
Feb 28, 2024
Product type
Drugs
Recall number
D-0327-2024
Classification
Class II
Recalling firm
Amneal Pharmaceuticals of New York, LLC
Product quantity
46,037 Bottles
Termination date
Feb 14, 2025
Reason for recall
Failed Impurities/Degradation Specifications: Out-of-specification test results.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC# 69238-1273-6
Distribution pattern
Nationwide in the USA
Recall initiation date
Feb 13, 2024
Initial firm notification
Letter
Center classification date
Feb 16, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0327-2024, published Feb 28, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls